Indicators
Indicators
Value
Direction
MACD(12,26,9)
0.156
Buy
RSI(14)
57.026
Neutral
STOCH(KDJ)(9,3,3)
67.499
Sell
ATR(14)
1.088
High Vlolatility
CCI(14)
50.659
Neutral
Williams %R
17.684
Overbought
TRIX(12,20)
0.400
Sell
StochRSI(14)
0.000
Oversold
Search
National Research Corp
NRCAdd to Watchlist
18.620USD
-0.310-1.64%
Close 05/15, 16:00（ET）Quotes delayed by 15 min
419.63MMarket Cap
47.47P/E TTM
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score of National Research Corp
Currency: USD Updated: 2026-05-15Key Insights
National Research Corp's fundamentals are relatively stable, with industry-average ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 95 out of 157 in the Professional & Commercial Services industry.Institutional ownership is very high.In the medium term, the stock price is expected to trend up.Despite an average stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
National Research Corp's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Neutral
National Research Corp Highlights
StrengthsRisks
National Research Corporation, doing business as NRC Health, is a provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare organizations in the United States. Its digital solutions consist of four solution categories: Patient Experience, Consumer Experience, Employee Experience, and Market Experience, which can be implemented both collectively as an enterprise solution or individually to meet specific needs within the organization. Its Marketing solutions are subscription-based services that allow for improved tracking of awareness, perception, and consistency of healthcare brands; real-time assessment of competitive differentiators, and enhanced segmentation tools. Its Reputation solutions allow healthcare organizations to share a picture of their organization and ensure that timely and relevant content informs better consumer decision-making.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 45.67%.
Stable Dividend
The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 45.67%.
Overvalued
The company’s latest PE is 46.51, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 12.06M shares, decreasing 6.40% quarter-over-quarter.
Held by CI Select Canadian Equity Fund
Star Investor CI Select Canadian Equity Fund holds 1.41K shares of this stock.
Analyst Rating
Based on
0
analysts
--
Current Rating
--
Target Price
--
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Financial Health
Currency: USD Updated: 2026-05-15The current financial score of National Research Corp is 7.51, ranking 67 out of 157 in the Professional & Commercial Services industry. Its financial status is weak, and its operating efficiency is average. Its latest quarterly revenue reached 34.80M, representing a year-over-year increase of 3.73%, while its net profit experienced a year-over-year increase of 44.32%.
Score
Financials
5.34
Key Metrics
Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
Relevant data have not been disclosed by the company yet.
Quality of Earnings
9.39
Operational Efficiency
7.61
Growth Potential
7.67
Shareholder Returns
7.55
National Research Corp's Company Valuation
Currency: USD Updated: 2026-05-15The current valuation score of National Research Corp is 6.14, ranking 108 out of 157 in the Professional & Commercial Services industry. Its current P/E ratio is 46.51, which is 3.06% below the recent high of 47.93 and 78.87% above the recent low of 9.83.
Score
Valuation Dimensions
P/E
P/B
P/S
P/CF
Industry Ranking 95/157
Relevant data have not been disclosed by the company yet.
Earnings Forecast
Currency: USD Updated: 2026-05-15No earnings forecast score is currently available for National Research Corp. The Professional & Commercial Services industry's average is 7.71.
Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
No Data
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Relevant data have not been disclosed by the company yet.
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Price Momentum
Currency: USD Updated: 2026-05-15The current price momentum score of National Research Corp is 9.13, ranking 16 out of 157 in the Professional & Commercial Services industry. Currently, the stock price is trading between the resistance level at 20.48 and the support level at 15.73, making it suitable for range-bound swing trading.
Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Indicators
The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.
This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.
Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.
Moving Average
Indicators
Value
Direction
MA5
18.824
Sell
MA10
18.642
Sell
MA20
17.906
Buy
MA50
17.364
Buy
MA100
17.336
Buy
MA200
16.049
Buy
Institutional Confidence
Currency: USD Updated: 2026-05-15The current institutional shareholding score of National Research Corp is 5.00, ranking 97 out of 157 in the Professional & Commercial Services industry. The latest institutional shareholding proportion is 53.51%, representing a quarter-over-quarter increase of 9.20%. The largest institutional shareholder is HOTCHKIS & WILEY, holding a total of 342.40K shares, representing 1.52% of shares outstanding, with 116.42% increase in holdings.
Score
Institutional Shareholding
Relevant data have not been disclosed by the company yet.
Risk Assessment
Currency: USD Updated: 2026-05-15The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Professional & Commercial Services domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of National Research Corp is 5.22, ranking 89 out of 157 in the Professional & Commercial Services industry. The company's beta value is 0.35. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets. National Research Corp’s latest ESG disclosure is at an average level in the Professional & Commercial Services industry, showing no material impact on overall risk.
Score
Beta vs S&P 500 index
0.35
VaR
+4.05%
240-Day Maximum Drawdown
+46.49%
240-Day Volatility
+56.36%
Return
Best Daily Return
60 days
+9.80%
120 days
+9.80%
5 years
+16.02%
Worst Daily Return
60 days
-8.56%
120 days
-19.54%
5 years
-19.54%
Sharpe Ratio
60 days
+3.58
120 days
+0.77
5 years
-0.27
Risk Assessment
Maximum Drawdown
240 days
+46.49%
3 years
+78.35%
5 years
+81.00%
Return-to-Drawdown Ratio
240 days
+0.76
3 years
-0.24
5 years
-0.16
Skewness
240 days
-0.53
3 years
-0.60
5 years
-0.60
Volatility
Realised Volatility
240 days
+56.36%
5 years
+43.55%
Standardised True Range
240 days
+4.34%
5 years
+5.62%
Downside Risk-Adjusted Return
120 days
+90.50%
240 days
+90.50%
Maximum Daily Upside Volatility
60 days
+47.65%
Maximum Daily Downside Volatility
60 days
+44.30%
Liquidity
Average Turnover Rate
60 days
+0.43%
120 days
+0.43%
5 years
--
Turnover Deviation
20 days
+6.04%
60 days
+1.98%
120 days
+1.54%
Peer Comparison
Professional & Commercial Services
National Research Corp
NRC
5.65 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Barrett Business Services Inc
BBSI
8.43 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Korn Ferry
KFY
8.41 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Ennis Inc
EBF
8.35 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Cimpress PLC
CMPR
8.34 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
United Rentals Inc
URI
8.34 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
